Therefore, the current study agrees with the study of Zhang and co-workers, who detected that by regulating fibroblast growth factor1 (FGF1) via miR-133a, TUG1 knockdown suppressed hyperlipidemia (Zhang et al., 2018). The gene discussed is FGF1; the disease is hyperlipidemia.